Cordlife Group (SG:P8A) has released an update.
Cordlife Group Limited’s newly appointed Group CEO announces a commitment to address recent challenges, including a suspension of cord blood and tissue collection in Singapore and an ongoing investigation. The CEO, also a client of Cordlife, promises to implement a comprehensive rectification plan with MOH to resume operations and restore stakeholder trust. The plan includes collaborating with industry experts and enhancing operational standards to prevent future lapses.
For further insights into SG:P8A stock, check out TipRanks’ Stock Analysis page.
